Related Experiment Video
Updated: Mar 21, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Tobacco Use Patterns in a Southern US HIV Clinic
Madelyne C Bean1, Lauren E Richey1, Kristen Williams1
1From the Departments of Medicine, Psychiatry and Behavioral Sciences, and Public Health Sciences, Medical University of South Carolina College of Medicine, Charleston.
Objectives:
Smoking rates are two to three times higher among people living with HIV and AIDS compared with the general population, but the prevalence of tobacco use among this population in the Charleston, SC region has not been established. To understand cigarette use, previous quit attempts, historic use of cessation therapies, and interest in cessation, a quality improvement project was implemented to survey smoking behaviors among this population.
Methods:
During January-May 2010, HIV-infected patients arriving to the Medical University of South Carolina Infectious Diseases clinic were asked to complete a survey. Clinical and sociodemographic data were collected and analyzed using χ(2), and one-way analysis of variance models.
Results:
Of unduplicated clinic encounters, 514 (75%) of patients completed the smoking survey. Less than half of responders were current (205, 40%) or former (42, 8%) smokers, with smoking prevalence higher for Caucasian males. Among current smokers, 170 (85%) reported having ever attempted to quit with the majority making a quit attempt without medication therapy (143, 83%). Nearly half of all current smokers (97, 49%) reported an active interest in speaking with a physician about quitting. Smoking status did not have meaningful relationships with HIV biomarkers, even when stratified by race and gender.
Conclusions:
This study supports that high rates of smoking exist in the south among people living with HIV and AIDS and demonstrated a need for smoking cessation interventions among these patients. These data have potentiated the hiring of a clinical pharmacist to aid in implementation of smoking cessation therapies in a more systematic and formal way.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Retrovirus Life Cycles
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

